Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
50,891 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00126893 | Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia | terminated | Phase 1 | 36 | Celgene CorporationINDUSTRY | 1 | May 15, 2007 | clinicaltrials |
| NCT00255333 | INNO-105 in Patients With Solid Tumors | terminated | Phase 1 | 24 | Innovive PharmaceuticalsINDUSTRY | 1 | May 14, 2007 | clinicaltrials |
| Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors. |
| completed |
| Phase 1 |
| — |
| Sunesis PharmaceuticalsINDUSTRY |
| 1 |
| May 10, 2007 |
| clinicaltrials |
| NCT00094159 | Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors | completed | Phase 1 | — | Sunesis PharmaceuticalsINDUSTRY | 1 | May 10, 2007 | clinicaltrials |
| NCT00054795 | Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) | completed | Phase 3 | 550 | Pharmacyclics LLC.INDUSTRY | 8 | May 8, 2007 | clinicaltrials |
| NCT00080028 | Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer | terminated | Phase 1 | 18 | Pharmacyclics LLC.INDUSTRY | 1 | May 8, 2007 | clinicaltrials |
| NCT00323583 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | unknown | Phase 2 | 80 | Seattle Cancer Treatment and Wellness CenterOTHER | 1 | May 8, 2007 | clinicaltrials |
| NCT00054886 | Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer | completed | Phase 2 | 63 | PfizerINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00066885 | Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 80 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00109356 | Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia | unknown | Phase 1 / Phase 2 | 55 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00034827 | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer | completed | Phase 2 | 172 | PfizerINDUSTRY | 1 | May 4, 2007 | clinicaltrials |
| NCT00039910 | Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia | completed | Phase 3 | 240 | PfizerINDUSTRY | 8 | May 4, 2007 | clinicaltrials |
| NCT00051051 | A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer | completed | Phase 2 | 168 | PfizerINDUSTRY | 9 | May 4, 2007 | clinicaltrials |
| NCT00105092 | Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | May 1, 2007 | clinicaltrials |
| NCT00135876 | Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients | completed | Phase 3 | 512 | Ontario Clinical Oncology Group (OCOG)OTHER | 4 | Apr 27, 2007 | clinicaltrials |
| NCT00299780 | Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. | completed | Phase 1 | 12 | Massachusetts General HospitalOTHER | 1 | Apr 24, 2007 | clinicaltrials |
| NCT00143884 | Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood | terminated | Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 23, 2007 | clinicaltrials |
| NCT00225056 | Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma | terminated | Phase 2 | 43 | Oncology Specialties, AlabamaOTHER | 1 | Apr 20, 2007 | clinicaltrials |
| NCT00336609 | TRIAD Burden of Illness Mucositis Study | unknown | — | 1,600 | TRIAD Burden of IllnessOTHER | 1 | Apr 20, 2007 | clinicaltrials |
| NCT00106262 | Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer | terminated | Phase 2 | 38 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Apr 18, 2007 | clinicaltrials |
| NCT00462189 | Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease | unknown | Phase 1 | 40 | Cambridge Antibody TechnologyOTHER | 3 | Apr 18, 2007 | clinicaltrials |
| NCT00234195 | Wellbutrin XL, Major Depressive Disorder and Breast Cancer | completed | Phase 4 | 25 | Thomas Jefferson UniversityOTHER | 1 | Apr 17, 2007 | clinicaltrials |
| NCT00239603 | Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate. | completed | — | 40 | Emory UniversityOTHER | 1 | Apr 17, 2007 | clinicaltrials |
| NCT00457860 | Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease | unknown | Phase 1 | 50 | Cambridge Antibody TechnologyOTHER | 2 | Apr 17, 2007 | clinicaltrials |
| NCT00089596 | Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers | completed | Phase 1 / Phase 2 | 10 | ViaCellINDUSTRY | 1 | Apr 12, 2007 | clinicaltrials |
| NCT00083785 | Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases | completed | Phase 2 | 25 | Light Sciences LLCINDUSTRY | 1 | Apr 11, 2007 | clinicaltrials |
| NCT00457808 | Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM | completed | Phase 2 | 25 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Apr 9, 2007 | clinicaltrials |
| NCT00330538 | Osteoporosis in Children With ALL | completed | — | 20 | Children's Mercy Hospital Kansas CityOTHER | 1 | Apr 6, 2007 | clinicaltrials |
| NCT00316433 | Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer | terminated | Phase 2 | 24 | Swedish Medical CenterOTHER | 1 | Apr 5, 2007 | clinicaltrials |
| NCT00251329 | Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery | unknown | Phase 2 | 48 | Cancer Research NetworkOTHER | 1 | Apr 4, 2007 | clinicaltrials |
| NCT00033878 | Study of Noni in Cancer Patients | completed | Phase 1 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Mar 28, 2007 | clinicaltrials |
| NCT00076609 | Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 31 | PhytoCeuticaINDUSTRY | 2 | Mar 28, 2007 | clinicaltrials |
| NCT00200837 | Ethnopharmacological Studies in Oral Medicine | completed | — | 1,000 | National Center for Complementary and Integrative Health (NCCIH)NIH | 3 | Mar 28, 2007 | clinicaltrials |
| NCT00195247 | Study Evaluating TTI-237 in Advanced Malignant Solid Tumors | terminated | Phase 1 | 45 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Mar 26, 2007 | clinicaltrials |
| NCT00195325 | Study Evaluating TTI-237 in Advanced Malignant Solid Tumors. | terminated | Phase 1 | 45 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Mar 26, 2007 | clinicaltrials |
| NCT00449982 | Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts | completed | Phase 3 | 480 | MediGeneINDUSTRY | 7 | Mar 21, 2007 | clinicaltrials |
| NCT00040625 | ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma. | approved for marketing | — | — | Eli Lilly and CompanyINDUSTRY | 4 | Mar 15, 2007 | clinicaltrials |
| NCT00161668 | Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care | completed | — | 500 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Mar 15, 2007 | clinicaltrials |
| NCT00116909 | A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy | completed | Phase 2 | 85 | OSI PharmaceuticalsINDUSTRY | 1 | Mar 14, 2007 | clinicaltrials |
| NCT00134186 | Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer | completed | Phase 2 | 43 | Pharmacyclics LLC.INDUSTRY | 1 | Mar 5, 2007 | clinicaltrials |
| NCT00052000 | A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer | completed | Phase 1 | 29 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 1, 2007 | clinicaltrials |
| NCT00441662 | Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema | completed | N/A | 170 | Wills EyeOTHER | 1 | Mar 1, 2007 | clinicaltrials |
| NCT00029523 | DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor | completed | Phase 4 | 100 | Pacira Pharmaceuticals, IncINDUSTRY | 2 | Feb 28, 2007 | clinicaltrials |
| NCT00114023 | 1-Year Follow up to the 1473-IMIQ Study | completed | — | 84 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00114920 | Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults | completed | Phase 2 | 88 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00115154 | Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands | completed | Phase 4 | 270 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00116662 | An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects | completed | Phase 2 | 84 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00116675 | Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects | completed | Phase 2 | 84 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00117871 | Study With a Topical Gel to Treat Common Warts in Adults | completed | Phase 2 | 48 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00117923 | Study With a Topical Gel to Treat Common Warts in Adults | completed | Phase 2 | 88 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials